Published in Am J Physiol Cell Physiol on January 19, 2011
Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg (2012) 1.78
Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J (2012) 1.25
CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS One (2012) 1.20
Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol (2011) 1.16
HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation. FASEB J (2011) 1.13
Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg (2012) 1.09
Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am J Physiol Heart Circ Physiol (2014) 1.01
Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One (2012) 0.96
Functional recovery of fluid drainage precedes lymphangiogenesis in acute murine foreleg lymphedema. Am J Physiol Heart Circ Physiol (2012) 0.94
The lymphatics and the inflammatory response: lessons learned from human lymphedema. Lymphat Res Biol (2013) 0.91
Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. Am J Physiol Cell Physiol (2011) 0.89
Lymph node transplantation results in spontaneous lymphatic reconnection and restoration of lymphatic flow. Plast Reconstr Surg (2014) 0.88
Th2 cytokines inhibit lymphangiogenesis. PLoS One (2015) 0.85
The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine. Sultan Qaboos Univ Med J (2015) 0.84
The alarmin HMGB-1 influences healing outcomes in fetal skin wounds. Wound Repair Regen (2013) 0.83
Sterile inflammation after lymph node transfer improves lymphatic function and regeneration. Plast Reconstr Surg (2014) 0.80
Galectin-1 regulates tissue exit of specific dendritic cell populations. J Biol Chem (2015) 0.79
Spatio-temporal changes of lymphatic contractility and drainage patterns following lymphadenectomy in mice. PLoS One (2014) 0.78
Emerging trends in the pathophysiology of lymphatic contractile function. Semin Cell Dev Biol (2015) 0.77
IL-6 regulates adipose deposition and homeostasis in lymphedema. Am J Physiol Heart Circ Physiol (2014) 0.77
High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway. PLoS One (2016) 0.77
Ultraviolet light exposure stimulates HMGB1 release by keratinocytes. Arch Dermatol Res (2013) 0.77
Cardiac Arrest Disrupts Caspase-1 and Patterns of Inflammatory Mediators Differently in Skin and Muscle Following Localized Tissue Injury in Rats: Insights from Data-Driven Modeling. Front Immunol (2015) 0.76
Characterization of internodal collecting lymphatic vessel function after surgical removal of an axillary lymph node in mice. Biomed Opt Express (2016) 0.75
Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model. Plast Reconstr Surg Glob Open (2014) 0.75
Inflammatory Manifestations of Lymphedema. Int J Mol Sci (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
The danger model: a renewed sense of self. Science (2002) 13.85
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2003) 8.34
HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 5.65
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep (2002) 4.76
The sterile inflammatory response. Annu Rev Immunol (2010) 3.45
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med (2006) 3.26
Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol (2007) 3.12
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol (2005) 2.96
Interstitial flow as a guide for lymphangiogenesis. Circ Res (2003) 2.82
Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol (2005) 2.78
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol (2004) 2.75
Incidence of breast carcinoma-related lymphedema. Cancer (1998) 2.71
HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med (2009) 2.56
Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol (2009) 2.45
High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol (2004) 2.32
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood (2009) 2.30
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med (2007) 2.29
Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol (2006) 2.14
Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol (2007) 2.12
A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol (2009) 1.99
Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol (2007) 1.98
High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res (2007) 1.89
Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol (2009) 1.87
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem (2007) 1.77
Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol (2010) 1.77
Regulation of monocyte migration by amphoterin (HMGB1). Blood (2004) 1.69
TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol (2008) 1.68
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther (2008) 1.65
Early events in the recognition of danger signals after tissue injury. J Leukoc Biol (2007) 1.65
Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J (2006) 1.50
Heat shock proteins: linking danger and pathogen recognition. Med Microbiol Immunol (2007) 1.45
Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol (2006) 1.42
Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med (2006) 1.41
High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol (2008) 1.36
The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.34
Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg (2009) 1.34
Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol (2007) 1.32
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol (2007) 1.31
Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol (2004) 1.19
Human lymphatic endothelial cells express multiple functional TLRs. J Immunol (2008) 1.18
High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol (2004) 1.16
HMGB1 in sepsis. Scand J Infect Dis (2003) 1.03
A direct inhibitor of HMGB1 cytokine. Chem Biol (2007) 1.00
Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg (1998) 0.96
The translocation of HMGB1 during cell activation and cell death. Autoimmunity (2009) 0.94
The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol (2006) 0.93
Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. J Leukoc Biol (2007) 0.88
Platelet-derived factors involved in tissue repair-from signal to function. Transfus Med Rev (2010) 0.88
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg (2013) 3.00
Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg (2007) 2.63
A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg (2013) 2.51
The effect of closed-suction drains on the incidence of local wound complications following tissue expander/implant reconstruction: a cohort study. Plast Reconstr Surg (2007) 2.27
Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. Plast Reconstr Surg (2010) 2.12
Technique of internal mammary dissection using pectoralis major flap to prevent contour deformities. Plast Reconstr Surg (2009) 2.05
Reconstruction of extensive composite posterolateral mandibular defects using nonosseous free tissue transfer. Plast Reconstr Surg (2009) 2.04
The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial. Plast Reconstr Surg (2012) 1.84
Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg (2012) 1.78
Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol (2010) 1.77
Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg (2008) 1.72
Immediate free flap reconstruction for advanced-stage breast cancer: is it safe? Plast Reconstr Surg (2011) 1.70
TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol (2008) 1.68
High cost of stage IV pressure ulcers. Am J Surg (2010) 1.68
Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J (2002) 1.67
Soft-tissue coverage of the hand following sarcoma resection. Plast Reconstr Surg (2008) 1.63
Ionizing radiation of mesenchymal stem cells results in diminution of the precursor pool and limits potential for multilineage differentiation. Plast Reconstr Surg (2008) 1.56
Reconstruction of complex oncologic chest wall defects: a 10-year experience. Ann Plast Surg (2004) 1.50
Postmastectomy reconstruction: an approach to patient selection. Plast Reconstr Surg (2009) 1.48
Does the use of biopatch devices at drain sites reduce perioperative infectious complications in patients undergoing immediate tissue expander breast reconstruction? Plast Reconstr Surg (2015) 1.42
Patient satisfaction with postmastectomy breast reconstruction: a comparison of saline and silicone implants. Cancer (2010) 1.41
Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med (2006) 1.41
Mast cells in the periprosthetic breast capsule. Aesthetic Plast Surg (2014) 1.39
The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis (2002) 1.35
Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg (2009) 1.34
Gorham's disease: an osseous disease of lymphangiogenesis? Ann N Y Acad Sci (2008) 1.29
Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J (2012) 1.25
Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg (2011) 1.21
CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS One (2012) 1.20
Trends in autologous fat grafting to the breast: a national survey of the american society of plastic surgeons. Plast Reconstr Surg (2013) 1.17
Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction. Ann Surg Oncol (2014) 1.16
Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol (2011) 1.16
Histologic analysis of angiogenesis and lymphangiogenesis in acellular human dermis. Plast Reconstr Surg (2008) 1.16
Scalp reconstruction: a 15-year experience. Ann Plast Surg (2004) 1.14
HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation. FASEB J (2011) 1.13
Diminishing relative contraindications for immediate breast reconstruction. Plast Reconstr Surg (2014) 1.12
The clinical spectrum of lymphatic disease. Ann N Y Acad Sci (2008) 1.11
Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol (2010) 1.09
Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg (2012) 1.09
The pedicled latissimus dorsi flap for shoulder reconstruction after sarcoma resection. Ann Surg Oncol (2007) 1.08
The impact of breast reconstruction on the oncologic efficacy of radiation therapy. Ann Plast Surg (2008) 1.07
Immediate postoperative complications in DIEP versus free/muscle-sparing TRAM flaps. Plast Reconstr Surg (2007) 1.07
Nipple-sparing mastectomy and immediate tissue expander/implant breast reconstruction. Plast Reconstr Surg (2009) 1.06
New developments in clinical aspects of lymphatic disease. J Clin Invest (2014) 1.04
The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: a matched-cohort study. Ann Plast Surg (2008) 1.03
Reconstruction of extremity long bone defects after sarcoma resection with vascularized fibula flaps: a 10-year review. Plast Reconstr Surg (2007) 1.03
Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One (2013) 1.02
An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs (2006) 1.02
Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci (2008) 1.00
A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer (2006) 1.00
The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: a U.S. population-based study. Plast Reconstr Surg (2012) 1.00
Anterior and middle cranial fossa skull base reconstruction using microvascular free tissue techniques: surgical complications and functional outcomes. Ann Plast Surg (2008) 0.99
The use of the extended anterolateral thigh flap for reconstruction of massive oncologic defects. Plast Reconstr Surg (2008) 0.97
Mechanisms of lymphatic regeneration after tissue transfer. PLoS One (2011) 0.97
Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One (2009) 0.96
p21cip/WAF is a key regulator of long-term radiation damage in mesenchyme-derived tissues. FASEB J (2010) 0.96
Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One (2012) 0.96
Immune traffic: a functional overview. Lymphat Res Biol (2003) 0.95
Complications in smokers after postmastectomy tissue expander/implant breast reconstruction. Ann Plast Surg (2005) 0.95
Coronary restenosis: a review of mechanisms and management. Am J Med (2003) 0.95
The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg (2007) 0.95
Endothelial dysfunction: clinical strategies for treating oxidant stress. Am Heart J (2003) 0.94
Chest and upper body morbidity following immediate postmastectomy breast reconstruction. Ann Surg Oncol (2013) 0.93
Breast cancer recurrence following prosthetic, postmastectomy reconstruction: incidence, detection, and treatment. Plast Reconstr Surg (2008) 0.93
Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat Res Biol (2009) 0.93
Reconstruction of extensive partial or total sacrectomy defects with a transabdominal vertical rectus abdominis myocutaneous flap. Ann Plast Surg (2006) 0.92
Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast Reconstr Surg (2002) 0.92
Animal models for the study of lymphatic insufficiency. Lymphat Res Biol (2003) 0.91
Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy. Ann Surg Oncol (2007) 0.91
Gene therapy in plastic surgery. Plast Reconstr Surg (2002) 0.91
The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg (2008) 0.90
Synthesis of a tissue-engineered periosteum with acellular dermal matrix and cultured mesenchymal stem cells. Tissue Eng Part A (2009) 0.90
Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. Am J Physiol Cell Physiol (2011) 0.89
Lymph node transplantation results in spontaneous lymphatic reconnection and restoration of lymphatic flow. Plast Reconstr Surg (2014) 0.88
Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat Res Biol (2013) 0.88
Essential role of Apelin signaling during lymphatic development in zebrafish. Arterioscler Thromb Vasc Biol (2013) 0.88
Outcome following removal of infected tissue expanders in breast reconstruction: a 10-year experience. Ann Plast Surg (2007) 0.88
Nipple-areola reconstruction following chest-wall irradiation for breast cancer: is it safe? Ann Plast Surg (2005) 0.87